# FRP Holdings, Inc.: overview

FRPH · Nasdaq · CIK 844059 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frph.md) · [Financials](/companies/frph/financials.md) · [Filings](/companies/frph/filings.md) · [Insiders](/companies/frph/insiders.md)

Latest reported revenue: [$11.1m](/filings/0000844059-26-000086.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000844059-26-000086).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.6](/filings/0000844059-25-000064.md) | [10.5 d](/filings/0000844059-26-000037.md) | [10.3](/filings/0000844059-26-000069.md) | [10.9](/filings/0000844059-26-000086.md) | [10.8](/filings/0000844059-25-000064.md) | [10.9 d](/filings/0000844059-26-000037.md) | [10.6](/filings/0000844059-26-000069.md) | [11.1](/filings/0000844059-26-000086.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [29.0%](/filings/0000844059-25-000064.md) | [27.7% d](/filings/0000844059-26-000037.md) | [22.6%](/filings/0000844059-26-000069.md) | [15.3%](/filings/0000844059-26-000086.md) | [12.6%](/filings/0000844059-25-000064.md) | [15.4% d](/filings/0000844059-26-000037.md) | [4.8%](/filings/0000844059-26-000069.md) | [13.2%](/filings/0000844059-26-000086.md) |
| Net margin | % | [12.8%](/filings/0000844059-25-000064.md) | [15.9% d](/filings/0000844059-26-000037.md) | [16.6%](/filings/0000844059-26-000069.md) | [5.3%](/filings/0000844059-26-000086.md) | [6.1%](/filings/0000844059-25-000064.md) | [3.5% d](/filings/0000844059-26-000037.md) | [(6.5%)](/filings/0000844059-26-000069.md) | [(2.3%)](/filings/0000844059-26-000086.md) |
| Diluted EPS | $ per share | [0.07](/filings/0000844059-25-000064.md) | not reported | [0.09](/filings/0000844059-26-000069.md) | [0.03](/filings/0000844059-26-000086.md) | [0.03](/filings/0000844059-25-000064.md) | not reported | [(0.04)](/filings/0000844059-26-000069.md) | [(0.01)](/filings/0000844059-26-000086.md) |
| Free cash flow | $m | [(28.2) d](/filings/0000844059-25-000064.md) | [3.5 d](/filings/0000844059-26-000037.md) | [1.4](/filings/0000844059-26-000069.md) | [2.6 d](/filings/0000844059-26-000086.md) | [(16.9) d](/filings/0000844059-25-000064.md) | [(8.6) d](/filings/0000844059-26-000037.md) | [(3.8)](/filings/0000844059-26-000069.md) | [(12.0) d](/filings/0000844059-26-000086.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [31.2](/filings/0000844059-24-000018.md) | [37.5](/filings/0000844059-25-000009.md) | [41.5](/filings/0000844059-26-000037.md) | [41.8](/filings/0000844059-26-000037.md) | [42.8](/filings/0000844059-26-000037.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.3%](/filings/0000844059-24-000018.md) | [21.3%](/filings/0000844059-25-000009.md) | [28.2%](/filings/0000844059-26-000037.md) | [28.0%](/filings/0000844059-26-000037.md) | [16.4%](/filings/0000844059-26-000037.md) |
| Net margin | % | [90.4%](/filings/0000844059-24-000018.md) | [12.2%](/filings/0000844059-25-000009.md) | [12.8%](/filings/0000844059-26-000037.md) | [15.3%](/filings/0000844059-26-000037.md) | [7.8%](/filings/0000844059-26-000037.md) |
| Diluted EPS | $ per share | [3.00](/filings/0000844059-24-000018.md) | [0.24](/filings/0000844059-25-000009.md) | [0.28](/filings/0000844059-26-000037.md) | [0.34](/filings/0000844059-26-000037.md) | [0.18](/filings/0000844059-26-000037.md) |
| Free cash flow | $m | [5.7](/filings/0000844059-24-000018.md) | [(5.3)](/filings/0000844059-25-000009.md) | [21.8](/filings/0000844059-26-000037.md) | [(22.2)](/filings/0000844059-26-000037.md) | [(21.5)](/filings/0000844059-26-000037.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/frph/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $48.3m | 1,931,562 |  | Added +4,695 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $27.7m | 1,110,253 |  | Added +49,186 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $27.5m | 1,098,484 |  | Reduced −37,604 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.0m | 519,009 |  | Added +8,964 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.1m | 322,153 |  | Added +34,996 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.8m | 313,797 |  | Added +17,463 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $7.2m | 289,588 |  | Added +134,308 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.1m | 284,690 |  | Added +798 |
| [SPROTT INC.](/funds/1512920.md) | 2026-06-30 | $7.1m | 284,340 |  | Unchanged |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $5.6m | 222,917 |  | Added +129,675 |

## Recent filings

[All 1,135 filings](/companies/frph/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 18:25 ET | [10-Q](/filings/0000844059-26-000086.md) | Quarterly report, period 2026-06-30 | 0000844059-26-000086 |
| 2026-08-04 | 16:08 ET | [8-K](/filings/0000844059-26-000083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000844059-26-000083 |
| 2026-05-15 | 10:46 ET | [8-K](/filings/0000844059-26-000071.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000844059-26-000071 |
| 2026-05-14 | 17:17 ET | [10-Q](/filings/0000844059-26-000069.md) | Quarterly report, period 2026-03-31 | 0000844059-26-000069 |
| 2026-05-13 | 10:15 ET | [8-K](/filings/0000844059-26-000060.md) | 5.07 Shareholder vote results | 0000844059-26-000060 |
| 2026-05-12 | 16:45 ET | [8-K](/filings/0000844059-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000844059-26-000058 |
| 2026-04-16 | 16:54 ET | [DEF 14A](/filings/0000844059-26-000041.md) | Proxy statement, period 2025-12-31 | 0000844059-26-000041 |
| 2026-04-15 | 16:01 ET | [10-K](/filings/0000844059-26-000037.md) | Annual report, period 2025-12-31 | 0000844059-26-000037 |
| 2026-04-10 | 16:15 ET | [8-K](/filings/0000844059-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000844059-26-000030 |
| 2026-03-25 | 17:28 ET | [SCHEDULE 13D/A](/filings/0000844059-26-000019.md) | Ownership report, active investor, amended | 0000844059-26-000019 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000844059-26-000037.md), filed Apr 15, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7307dde6-6921-4a93-a921-0132ccb1fe85)

## About the filer

- CIK: 844059
- Tickers: FRPH
- Exchange: Nasdaq
- SIC code: 6500 Real Estate
- State of incorporation: FL
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.
